Recent clinical trials evaluating benefit of drug therapy for modification of HDL cholesterol

Medicine & Life Sciences

• Niacin 100%
• HDL Cholesterol 90%
• evacetrapib 78%
• anacetrapib 73%
• dalcetrapib 73%
• torcetrapib 70%
• Clinical Trials 65%
• Drug Therapy 59%
• Cholesterol Ester Transfer Proteins 56%
• Hydroxymethylglutaryl-CoA Reductase Inhibitors 39%
• Computer Security 28%
• Pharmacology 26%
• Risk Reduction Behavior 20%
• Global Health 19%
• Metabolic Syndrome 18%
• Triglycerides 16%
• Randomized Controlled Trials 13%
• Health Care Outcome Assessment 13%
• Lipids 13%
• Therapeutics 13%
• Heart 13%
• Blood Vessels 11%
• Mortality 10%
• Incidence 9%